MedTrace Logo

A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS)

NCT00821002 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2013-09-19

No results posted yet for this study

Summary

The study objective is to compare IOP and safety outcomes based on plug placement (upper or lower puncta).

Conditions

Interventions

DRUG

Latanoprost

Comparison of punctal plug placement between upper and lower puncta

Sponsors & Collaborators

  • QLT Inc.

    collaborator INDUSTRY

  • Mati Therapeutics Inc.

    lead INDUSTRY

Principal Investigators

  • Oscar Cuzanni, MD, MSc · QLT Inc.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-11-30
Completion
2009-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00821002 on ClinicalTrials.gov